Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lonberg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Medical Clinics of North America|January 1, 1986
Kaposi's sarcoma and AIDSF M Muggia, M Lonberg
Cancer Research|March 1, 1990
Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activityP B Chapman, M Lonberg, A N Houghton
Progress in Clinical and Biological Research|January 1, 1989
Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 gangliosideA N Houghton, D F Bajorin, M Lonberg, et al.
Journal of Biological Response Modifiers|August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposideR L Krigel, C M Slywotzky, M Lonberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Medical Clinics of North America|January 1, 1986
Kaposi's sarcoma and AIDSF M Muggia, M Lonberg
Cancer Research|March 1, 1990
Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activityP B Chapman, M Lonberg, A N Houghton
Progress in Clinical and Biological Research|January 1, 1989
Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 gangliosideA N Houghton, D F Bajorin, M Lonberg, et al.
Journal of Biological Response Modifiers|August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposideR L Krigel, C M Slywotzky, M Lonberg, et al.
Pageof 1